| Isabel Bass, MD | |
|
4502 Medical Dr, San Antonio, TX 78229-4402 | |
| (210) 257-1400 | |
| Not Available |
| Full Name | Isabel Bass |
|---|---|
| Gender | Female |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 4502 Medical Dr, San Antonio, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033226105 | NPI | - | NPPES |
| 181009502 | Other | TX | CIDC |
| 181009501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | M2899 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Isabel Bass, MD Uthscsa, Uthscsa, Dept. Of Radiology, 7703 Floyd Curl Drive, Rm 636f, San Antonio, TX 78229 Ph: (210) 567-3448 | Isabel Bass, MD 4502 Medical Dr, San Antonio, TX 78229-4402 Ph: (210) 257-1400 |
News Archive
ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.
Although colorectal cancer is associated with obesity, it is unclear if weight loss surgery impacts the incidence of these tumors.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.
Svelte Medical Systems today announced completion of enrollment in the DIRECT (Direct Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study conducted at four investigational sites in New Zealand.
› Verified 1 days ago
Dr. Amy Benson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 311 Camden St, Suite 208, San Antonio, TX 78215 Phone: 210-892-0228 Fax: 210-455-0169 | |
Calvin Leuschen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-257-1400 | |
Dr. Sarah Morris Rothan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 8401 Datapoint Dr Ste 600, San Antonio, TX 78229 Phone: 210-616-7784 | |
Eric Ortega, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7703 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-567-7000 | |
Michael Mccarthy, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7703 Floyd Curl Dr, Mc 7977, San Antonio, TX 78229 Phone: 210-257-1400 Fax: 210-257-1428 | |
Dr. Gladys S. Sepulveda, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 8401 Datapoint Dr, Suite 600, San Antonio, TX 78229 Phone: 210-616-7700 | |
Dr. John H. Gurian, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8401 Datapoint Dr, Suite 600, San Antonio, TX 78229 Phone: 210-616-7700 Fax: 210-616-7709 |